ADA Advises Against Using Compounded GLP-1 RA Medications
In a new statement, the American Diabetes Association (ADA) has advised against the use of compounded glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RA medication classes.
New Trial Result Pushes Past Antiarrhythmic Therapy After MI
For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy, which is typically used first, the multinational VANISH2 trial shows.
ESC/EACTS to Review Left Main Revascularization Guidance Patrice Wendling
The European Society of Cardiology and European Association for Cardiothoracic Surgery (ESC/EACTS) have announced they will review their joint recommendations for left main coronary artery disease in light of emerging data.
Russian National Congress of Cardiology 2020
CONFERENCE NEWS
World Heart Day
On World Heart Day, 29 September 2020, we’re asking the world to Use Heart to beat CVD ... for your loved ones, society and you.
European Society of Cardiology (ESC) Congress 2020.
CONFERENCE NEWS
Major Indexing Service Calls Out Cardiology Journals for Self-Citation
More than 70% of the citations in one journal were to other papers in that journal. Another published a single paper that cited nearly 200 other articles in the journal.
Novel Lipid Therapies: 5 Things to Know
The development of novel pharmacotherapies targeting low-density lipoprotein (LDL), lipoprotein a, and triglycerides (TG) to help prevent patients' risk of atherosclerotic cardiovascular disease (ASCVD) has accelerated during the past decade.
COVID-19 and cardiovascular diseases: main aspects
Igor S. Yavelov MD, PhD, Professor of cardiology
Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov.
Dear Colleagues!
On April 27, 2021, at the initiative of the Indonesian Society of Cardiology, an online meeting was held with one of the leading experts of Russia in the cardiology, Professor Mekhman N Mamedov.